Cargando…

P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS

Detalles Bibliográficos
Autores principales: Minnema, Monique, Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula, Lung Wu, Ka, José Kersten, Marie, Croockewit, Sandra, de Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemiek, Schönland, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431063/
http://dx.doi.org/10.1097/01.HS9.0000970500.50569.c6
_version_ 1785091110441320448
author Minnema, Monique
Nasserinejad, Kazem
Hegenbart, Ute
Ypma, Paula
Lung Wu, Ka
José Kersten, Marie
Croockewit, Sandra
de Waal, Esther
Zweegman, Sonja
Tick, Lidwien
Broijl, Annemiek
Schönland, Stefan
author_facet Minnema, Monique
Nasserinejad, Kazem
Hegenbart, Ute
Ypma, Paula
Lung Wu, Ka
José Kersten, Marie
Croockewit, Sandra
de Waal, Esther
Zweegman, Sonja
Tick, Lidwien
Broijl, Annemiek
Schönland, Stefan
author_sort Minnema, Monique
collection PubMed
description
format Online
Article
Text
id pubmed-10431063
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310632023-08-17 P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS Minnema, Monique Nasserinejad, Kazem Hegenbart, Ute Ypma, Paula Lung Wu, Ka José Kersten, Marie Croockewit, Sandra de Waal, Esther Zweegman, Sonja Tick, Lidwien Broijl, Annemiek Schönland, Stefan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431063/ http://dx.doi.org/10.1097/01.HS9.0000970500.50569.c6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Minnema, Monique
Nasserinejad, Kazem
Hegenbart, Ute
Ypma, Paula
Lung Wu, Ka
José Kersten, Marie
Croockewit, Sandra
de Waal, Esther
Zweegman, Sonja
Tick, Lidwien
Broijl, Annemiek
Schönland, Stefan
P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title_full P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title_fullStr P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title_full_unstemmed P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title_short P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
title_sort p899: hovon 104; long term follow-up of autologous stem cell transplantation after bortezomib induction therapy in patients with newly diagnosed al amyloidosis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431063/
http://dx.doi.org/10.1097/01.HS9.0000970500.50569.c6
work_keys_str_mv AT minnemamonique p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT nasserinejadkazem p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT hegenbartute p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT ypmapaula p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT lungwuka p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT josekerstenmarie p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT croockewitsandra p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT dewaalesther p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT zweegmansonja p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT ticklidwien p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT broijlannemiek p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis
AT schonlandstefan p899hovon104longtermfollowupofautologousstemcelltransplantationafterbortezomibinductiontherapyinpatientswithnewlydiagnosedalamyloidosis